PEAK6 Group’s Sanofi SNY Stock Holding History

PEAK6 Group’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-25,100	Closed	-$1.14M	–	4987
2017 Q1	$1.14M	Sell	25,100 -38,900	-61%	-$1.65M	0.01%	1569
2016 Q4	$2.59M	Buy	64,000 +26,700	+72%	+$1.05M	0.02%	1120
2016 Q3	$1.42M	Sell	37,300 -18,900	-34%	-$758K	0.01%	1518
2016 Q2	$2.35M	Buy	56,200 +43,400	+339%	+$1.78M	0.02%	1117
2016 Q1	$514K	Sell	12,800 -12,600	-50%	-$506K	﹤0.01%	2266
2015 Q4	$1.08M	Sell	25,400 -18,200	-42%	-$837K	0.01%	1857
2015 Q3	$2.07M	Buy	43,600 +25,800	+145%	+$1.31M	0.01%	1557
2015 Q2	$882K	Buy	+17,800	New	+$902K	0.01%	2213
2014 Q4	–	Sell	-10,600	Closed	-$598K	–	5108
2014 Q3	$598K	Buy	+10,600	New	+$569K	﹤0.01%	2314
2014 Q2	–	Sell	-86,300	Closed	-$4.51M	–	5087
2014 Q1	$4.51M	Buy	86,300 +63,300	+275%	+$3.2M	0.04%	698
2013 Q4	$1.23M	Sell	23,000 -66,000	-74%	-$3.41M	0.01%	1870
2013 Q3	$2.26M	Buy	89,000 +59,100	+198%	+$3.01M	0.02%	1421
2013 Q2	$1.54K	Buy	+29,900	New	+$1.59M	0.01%	1763

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PEAK6 Group's SNY Position: Q2 2016 in Review

PEAK6 Group sold out of Sanofi (SNY) in Q2 2016, closing a stake of 5,357 shares — an estimated $220K sold.

PEAK6 Group first reported a position in SNY in Q2 2013 and held it in 8 quarters. The position peaked at $661K in Q1 2014. 449 funds tracked by Wall St. Rank hold SNY as of Q2 2016.

PEAK6 Group reported no remaining Sanofi position as of Q2 2016 after selling out during the quarter.
PEAK6 Group sold 5,357 Sanofi shares in Q2 2016, an estimated $220K.
PEAK6 Group first reported a position in Sanofi in Q2 2013 and held it in 8 quarters.
PEAK6 Group's Sanofi position peaked at $661K in Q1 2014.
449 funds tracked by Wall St. Rank held Sanofi as of Q2 2016.

Based on PEAK6 Group's 13F filing for Q2 2016, filed 10 Aug 2016.